• Plantaricin A Analogs Lower Gram-Negative Resistance to Anti

  2026-05-14

  This study demonstrates that Plantaricin A analogs, particularly OP4, can permeabilize the outer membrane of Gram-negative bacteria, thereby enhancing the efficacy of hydrophobic antibiotics. The findings offer a promising strategy to address intrinsic antibiotic resistance and highlight the importance of membrane-targeting peptides in combination therapies.

• Structural and Functional Advances in Oudemansiella raphanip

  2026-05-13

  This study provides a comprehensive structural and functional characterization of Oudemansiella raphanipies polysaccharides, employing ultrasonic-assisted extraction to maximize yield and bioactivity. Notable findings include high antioxidant capacity, prebiotic potential, and detailed insights into oral absorption and in vivo distribution, supporting their use as innovative functional food additives.

• Lysoptosis: An Evolutionarily Conserved Cell Death Pathway

  2026-05-13

  This article examines newly characterized lysoptosis, a lysosome-dependent cell death pathway defined by lysosomal membrane permeabilization and cathepsin release, as described by Luke et al. The study reveals the evolutionary conservation of lysoptosis and the critical moderating role of intracellular serpins, offering mechanistic insights relevant for apoptosis and cancer research.

• Pioglitazone: PPARγ Agonist Workflows for Inflammation Model

  2026-05-12

  Pioglitazone, a potent PPARγ agonist from APExBIO, enables precise modeling of macrophage polarization and inflammation in type 2 diabetes mellitus and IBD research. This article delivers actionable protocols, troubleshooting tips, and advanced applications, translating cutting-edge evidence into reproducible bench workflows.

• Escitalopram in Translational Neuroscience: Mechanism to Imp

  2026-05-12

  This thought-leadership article provides translational researchers with a mechanistic and strategic roadmap for leveraging Escitalopram (Lexapro) in antidepressant and anxiolytic activity studies. It synthesizes evidence from clinical trials, workflow protocols, and competitive insights to guide assay optimization, highlight translational relevance, and chart a forward-looking vision for research impact. The article contextualizes APExBIO’s Escitalopram product as a benchmark for selectivity and reproducibility, bridging foundational neurobiology with advanced assay design.

• Ertapenem Sodium Salt: Applied Workflows for Resistance Rese

  2026-05-11

  Ertapenem sodium salt enables precise modeling of bacterial resistance and pharmacokinetics in both Gram-positive and Gram-negative bacteria. This guide translates recent transmission dynamics findings into actionable protocols, troubleshooting steps, and advanced applications for translational microbiology.

• Rosiglitazone (SKU A4304): Reliable PPARγ Modulation in Cell

  2026-05-11

  This article addresses reproducibility and workflow challenges in cell viability and metabolic assays, using Rosiglitazone (SKU A4304) as a validated solution. Drawing on recent literature and practical Q&A, it guides biomedical researchers in optimizing PPARγ-driven experimental designs for type II diabetes and adipogenesis research.

• Cycloastragenol Sensitizes Radiotherapy in Brain Metastatic

  2026-05-10

  This study demonstrates that cycloastragenol (CAG) significantly enhances radiotherapy efficacy while mitigating brain injury in a mouse model of lung cancer brain metastases. Mechanistic investigations reveal CAG’s dual role in radiosensitization and neuroprotection via modulation of key inflammatory pathways, offering new insight for combination treatments against metastatic brain tumors.

• Cannabidiol Modulates Orofacial Pain via Endocannabinoid and

  2026-05-09

  This study establishes that cannabidiol (CBD) exerts robust effects on both sensory and affective components of orofacial inflammatory pain in mice. Through comprehensive behavioral, molecular, and neurocircuit analyses, the paper demonstrates a dual modulatory mechanism involving peripheral CB2 and central CB1 receptor pathways alongside normalization of serotonin signaling, providing translational insight for pain management.

• Localized BDNF Release Orchestrates Postsynaptic NMJ Formati

  2026-05-08

  This study reveals that muscle-generated BDNF, released in a spatially and activity-dependent manner, is essential for the initial formation of postsynaptic acetylcholine receptor (AChR) clusters at neuromuscular junctions (NMJs). By dissecting the trafficking, localization, and proteolytic processing of BDNF in muscle cells, the work clarifies the mechanisms underlying early NMJ development and offers precise molecular targets for future research.

• Nystatin (Fungicidin): Beyond Candida—Precision Antifungal R

  2026-05-08

  Explore the multifaceted antifungal power of Nystatin (Fungicidin) and its advanced applications in mycoses research. This article reveals new scientific depth on mechanistic action, resistance challenges, and translational assay design, setting it apart as a unique cornerstone resource.

• Ranolazine: Anti-Ischemic Agent Workflows and Troubleshootin

  2026-05-07

  Ranolazine uniquely combines late sodium current inhibition and metabolic modulation, making it a pivotal anti-ischemic agent in cardiac and metabolic research. This guide provides actionable protocols, addresses common pitfalls, and connects metabolic crosstalk insights to robust experimental design.

• LY2603618: Deep Mechanistic Insights and Assay Optimization

  2026-05-07

  Explore how the Chk1 inhibitor LY2603618 transforms cancer research by offering advanced assay optimization, mechanistic depth, and evidence-driven workflows. Uncover a distinct perspective on DNA damage response modulation and chemotherapy sensitization.

• N3-kethoxal: Deep-Dive into RNA-Protein Proximity Mapping

  2026-05-06

  Explore how N3-kethoxal enables unprecedented precision in RNA-protein interaction mapping and nucleic acid structure analysis. This article provides a unique, evidence-backed perspective on assay design, protocol parameters, and the scientific advances enabled by this azide-functionalized probe.

• Biotin-HPDP in Thiol-Specific Protein Labeling: Workflows &

  2026-05-06

  Biotin-HPDP delivers unparalleled specificity and reversibility for thiol-modification of proteins, enabling dynamic analyses in redox biology and immuno-oncology. This article details practical workflows, experimental enhancements, and troubleshooting strategies—anchored by recent discoveries in cancer immunometabolism.

16198 records 3/1080 page Previous Next 12345 下5页 Last page